ST · Healthcare

BioGaia AB (publ) (BIOG-B)

Drug Manufacturers - Specialty & Generic

BioGaia AB (publ) (BIOG-B) is listed on ST in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BIOG-B

P/E ratio

18.00

BioGaia AB (publ) (BIOG-B) — FAQ

What is BIOG-B's P/E ratio?

The price-to-earnings (P/E) ratio for BioGaia AB (publ) (BIOG-B) is 18.00 (data as of 2026-05-24).

Does BioGaia AB (publ) pay a dividend?

Dividend yield is not available in the current snapshot for BioGaia AB (publ) (BIOG-B). Check the MyAverix Finance app for the latest dividend data.

What sector is BioGaia AB (publ) in?

BioGaia AB (publ) (BIOG-B) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is BIOG-B listed on?

BIOG-B is listed on ST.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)